Serum hepcidin was found to be greatly increased in patients with inflammation defined as CRP >10 mg/dL, patients with sepsis, burns, inflammatory bowel disease, and multiple myeloma [13, 35–37]. Here, HAMP is linked to plasma cell myeloma.